We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.

Katherine Shares Her Story with the Media


First Oncotype DX Patient Featured in Multiple TV Interviews

Breast Cancer Awareness Month is an important opportunity to educate the public about breast cancer and to help ensure breast cancer patients have access to standard of care, including requesting a genomic test when determining whether to undergo chemotherapy. In Sacramento, the message was shared through interviews featuring Katherine Young, the first Oncotype DX patient, on the local ABC, CBS, and Fox television stations.

In her interviews, Katherine – a 13-year breast cancer survivor – shared her experience as the first patient whose tumor was analyzed by the Oncotype DX test. Diagnosed in 2003, she had a double mastectomy and was advised by three different oncologists to receive chemotherapy. However, after reading an article in the Wall Street Journal about a new genomic test that could help determine whether or not she would benefit from chemotherapy, she decided to ask her doctor about Oncotype DX before making a treatment decision. She worked with her doctor to get the test and discovered she had a low Recurrence Score. Based on this personalized genomic information, she was able to forego chemotherapy and its challenging side effects, which allowed her to continue her practice as a podiatrist.

In California, only one-third of women with breast cancer receive the Oncotype DX test, even though it is considered standard of care and is widely covered by insurers. Katherine stressed the critical need for patients to be their own advocates taking an active role in their cancer care.


Learn more about Katherine’s story

Oncotype DX My Colon Cancer Coach